U.S. health agency advises easing federal marijuana restrictions
Health and Human Services Secretary Xavier Becerra said Wednesday that federal health officials had delivered "a scheduling recommendation for marijuana" to the Drug Enforcement Administration, and Senate Democrats confirmed that HHS's advice was to ease up. President Biden had asked HHS to review marijuana's legal classification last October, at the same time he pardoned thousands of Americans convicted of "simple possession" of the drug.
Currently, marijuana is classified as a Schedule I drug, like heroin and LSD. Senate Majority Leader Chuck Schumer (D-N.Y.) said HHS urged the DEA to make it a Schedule III drug, the same tier as ketamine and some anabolic steroids. "HHS has done the right thing," Schumer said. "DEA should now follow through on this important step to greatly reduce the harm caused by draconian marijuana laws." The DEA's review of the proposed policy change could take months.
Rescheduling marijuana "would reduce or potentially eliminate criminal penalties for possession," The Associated Press explained. It wouldn't legalize the drug but it would make it easier to research the health benefits and drawbacks of cannabis, and it would remove many federal hurdles for selling the drug in the 23 states that have legalized recreational use and the 38 states where marijuana is legal for medicinal use, The Washington Post added.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We believe that rescheduling to Schedule III will mark the most significant federal cannabis reform in modern history," said Edward Conklin of the U.S. Cannabis Council. "President Biden is effectively declaring an end to Nixon's failed war on cannabis and placing the nation on a trajectory to end prohibition." Sen. Ron Wyden (D-Ore) agreed that making marijuana a Schedule III drug is "is not inconsequential," but he urged Congress to deschedule it altogether.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
'New arrivals are more than paying for themselves'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
6 stylish homes in Portland, Oregon
Feature Featuring a wall of windows in Collins View and a historic ballroom in Portland Heights
By The Week US Published
-
What's next for US interest rates?
The Explainer Stubborn inflation forestalls anticipated rate cuts
By Becca Stanek, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Narcan is becoming harder to find at drugstores across America
Under the Radar The drug, also known as naloxone, reverses the effects of an opioid overdose
By Justin Klawans, The Week US Published
-
The lows of an unregulated high: Teens are using marijuana alternative delta-8
In the Spotlight More than 1 in 10 high school seniors have reported using the substance, which contains concentrated THC
By Justin Klawans, The Week US Published
-
Tianeptine: why lawmakers fear a new kind of opioid
The explainer The drug is sold over the counter. And is highly addictive.
By Devika Rao, The Week US Published
-
The pros and cons of compounding pharmacies
Pros and cons Customizing medications can be lifesaving and also dangerous
By Devika Rao, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published